ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2543

Meta-Analysis Examining the Clinical Significance of Monitoring of Hydroxychloroquine Levels in SLE

Shivani Garg1, Rachna Unnithan 2, Karen Hansen 3, Nathalie Costedoat-Chalumeau 4 and Christie Bartels 1, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2UW- Madison, Madison, 3UW Madison, Madison, 4Cochin University Hospital, Paris, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: adherence, Disease Activity and flare, HCQ, level

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Session Title: SLE – Clinical Poster III: Treatment

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Despite the pivotal role hydroxychloroquine (HCQ) plays in treating SLE, less than 50% of patients take HCQ as prescribed. Nonadherence versus lack of effect to HCQ are difficult to distinguish, underscoring the importance of measuring HCQ blood levels to assess adherence. Despite this, information and consensus on the clinical impact of incorporating routine testing of HCQ blood levels is lacking. Therefore, we systematically reviewed publications examining the correlation between 1) HCQ levels and adherence, and 2) HCQ levels and SLEDAI scores, in SLE patients. We hypothesized that low HCQ levels would correlate with nonadherence and higher SLEDAI scores.

Methods: A comprehensive search was performed using MeSH heading and keywords in Medline, Embase, CINHL and Web of Science databases. We selected observational and interventional studies that measured HCQ levels and assessed adherence and/or SLEDAI scores in adults with SLE. Newcastle Ottawa Scale and Cochrane Collaboration Risk Assessment tools were used to rate the quality of observational and intervention studies, respectively. We used Forest plots to compare pooled estimates (95% CI) of correlations between HCQ levels and patient or physician reported nonadherence and SLEDAI scores. Heterogeneity was assessed using I2. 

Results: From 306 manually reviewed abstracts, four studies analyzing correlation between HCQ levels and adherence, and five studies examining the correlation between SLEDAI and HCQ blood levels, met inclusion criteria. The odds of nonadherence measured by physician or reported by the patient was 3 times higher in patients with below threshold HCQ blood levels, compared to those with higher HCQ blood levels (OR 2.95, 95% CI 1.63, 5.35, p < 0.001, I2 49%) (Figure 1). The mean SLEDAI score was 3.33 points higher in groups with HCQ levels below threshold levels, but this trend was not statistically significant (δ3.33, 95% CI -0.60, 7.26, p=0.097, I2 99%) (Figure 2). Risk of bias assessment revealed three poor quality studies which were excluded in sensitivity analysis; results remained unchanged. Limitations of our analysis include study heterogeneity and lack of consensus on optimal blood HCQ levels.

Conclusion: We found a good correlation between HCQ levels and non-adherence. While patients with low HCQ levels had higher SLEDAI scores, the p-value for this finding was not statistically significant. Future studies should clarify optimal blood HCQ levels to control lupus, and then investigate the value of measuring blood HCQ levels in clinical care.


Figure 1

Figure 1. Forest Plot of correlation of measured HCQ blood levels with assessed adherence


Figure 2

Figure 2. Forest Plot of correlation of measured HCQ blood levels with SLEDAI scores


Disclosure: S. Garg, None; R. Unnithan, None; K. Hansen, None; N. Costedoat-Chalumeau, None; C. Bartels, Pfizer, 2, Pfizer Independent Grants for Learning and Change, 2.

To cite this abstract in AMA style:

Garg S, Unnithan R, Hansen K, Costedoat-Chalumeau N, Bartels C. Meta-Analysis Examining the Clinical Significance of Monitoring of Hydroxychloroquine Levels in SLE [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/meta-analysis-examining-the-clinical-significance-of-monitoring-of-hydroxychloroquine-levels-in-sle/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/meta-analysis-examining-the-clinical-significance-of-monitoring-of-hydroxychloroquine-levels-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences